Dr. Limvarapuss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Hospital Dr
Suite # 110
Vallejo, CA 94589Phone+1 707-551-3300Fax+1 707-551-3301
Summary
- Dr. Chainarong Limvarapuss is an oncologist in Vallejo, CA and is affiliated with multiple hospitals in the area, including Sutter Solano Medical Center and NorthBay Medical Center. He received his medical degree from Siriraj Medical School/Mahidol University and has been in practice 28 years. He also speaks multiple languages, including Japanese and Thai. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 1998
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1995
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1992 - 1993
Siriraj Medical School/Mahidol UniversityClass of 1989
Certifications & Licensure
CA State Medical License 2002 - 2026
FL State Medical License 1997 - 2005
TN State Medical License 1998 - 2004
VA State Medical License 2001 - 2004
IL State Medical License 1997 - 2002
SC State Medical License 1998 - 1998- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
- realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL Start of enrollment: 2021 Sep 20
Roles: Contact
Publications & Presentations
PubMed
- 119 citationsDeep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identificationBrendan Bulik-Sullivan, Jennifer Busby, Christine D. Palmer, Matthew J. Davis, Tyler Murphy
Nature Biotechnology. 2019-01-01 - 11 citationsA new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model.Ramzi M. Mohammad, C. Limvarapuss, Nathan R. Wall, Nayera Hamdy, Frances W.J. Beck
International Journal of Oncology. 1999-08-01 - 5 citationsElastase activity of endocervical mucus in normal pregnancy.Chainarong Limvarapuss, Naohiro Kanayama, Toshihiko Terao
Asia-Oceania Journal of Obstetrics and Gynaecology. 2010-05-24
Press Mentions
Solano Hematology Oncology Adopts Deep Lens’ VIPER™ to Improve Patient Access to Clinical TrialsFebruary 24th, 2021
Professional Memberships
- Member
Other Languages
- Japanese, Thai
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
